Partners at the American Cancer Society and the National HPV Vaccination Roundtable are sharing with physicians new evidence, recently published, on the impact of initiating HPV vaccination at ages 9-10. The collection of evidence includes population studies, quality improvement projects, brief reports, and commentaries from experts in the field.
According to 2021 data from the Centers for Disease Control and Prevention (CDC), only 66 percent of Minnesota teens ages 13-17 were up-to-date on HPV vaccination. The HPV vaccine has been proven effective in preventing cancers caused by the HPV virus.
The collection of 10+ published articles shows the benefits, effectiveness, and acceptability of routinely recommending HPV vaccination for all preteens starting at age nine.
